about
Metabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular DystrophyTaurine: the appeal of a safe amino acid for skeletal muscle disordersTaurine supplementation increases skeletal muscle force production and protects muscle function during and after high-frequency in vitro stimulationThe different impact of a high fat diet on dystrophic mdx and control C57Bl/10 miceTissue taurine depletion alters metabolic response to exercise and reduces running capacity in mice.Ion channel pharmacology.Abnormalities in brain structure and biochemistry associated with mdx mice measured by in vivo MRI and high resolution localized (1)H MRS.Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium.Increased taurine in pre-weaned juvenile mdx mice greatly reduces the acute onset of myofibre necrosis and dystropathology and prevents inflammation.Early metabolic changes measured by 1H MRS in healthy and dystrophic muscle after injuryLevels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy.Cardiac and skeletal muscle abnormality in taurine transporter-knockout mice.Neurogenic muscle cramps.Chondrocytic cells express the taurine transporter on their plasma membrane and regulate its expression under anisotonic conditions.Taurine rescues cisplatin-induced muscle atrophy in vitro: a morphological study.The beneficial effects of taurine to counteract sarcopenia.Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.The Effect of Taurine on the Recovery from Eccentric Exercise-Induced Muscle Damage in Males.Benefits of Prenatal Taurine Supplementation in Preventing the Onset of Acute Damage in the Mdx Mouse.Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy.The effect of taurine and β-alanine supplementation on taurine transporter protein and fatigue resistance in skeletal muscle from mdx mice.Does a physiological concentration of taurine increase acute muscle power output, time to fatigue, and recovery in isolated mouse soleus (slow) muscle with or without the presence of caffeine?
P2860
Q26772002-331C3F3C-E7CB-45A4-B7E6-0D4BE1841D56Q26799770-4D1929A5-EAC1-4317-8623-F3668FE7A7F3Q28567907-49783211-7824-42E1-8AF7-3D4D03BECBB0Q34077151-5CEA0712-CA43-4F7F-B46D-FB8DA2856FE9Q34588672-5A570BCC-F9C4-4A46-8A00-D61357109C96Q34613758-8E3DF505-93B2-4F00-8A80-901055B09C89Q36075156-165B27DB-61E2-4611-BE1B-88161597DA69Q36094250-E9BA3801-EE82-485C-B7A9-D2FCDA6F2BB0Q36146630-52E00FB6-D3CA-412B-AD91-7F314EFA874DQ36320857-C82C7628-9BA6-4B0A-9460-D44C31C2D702Q37246026-D74F8206-3EAD-430C-A5F3-D18984FC3E8BQ37784046-7E323310-E7F3-4094-9510-3D3699293A9AQ38352222-E835F4A7-D5AF-4485-B701-334983663CDEQ38929289-EA19CC50-C125-4468-8B23-EAE9237AB01CQ38982099-06FBFB38-267A-422F-A17E-7A0CAAE92879Q39016892-A3631AD7-1C3C-4CE9-B8A7-104115CE1139Q40219200-47F99344-4355-470F-81BA-9457381517BFQ46283042-EC39169E-F4F3-4F05-87CB-3433D6BBA51AQ47349229-582970D7-B7C2-4D1C-BDB7-5300E76C01B4Q48133974-25DB353A-4A1E-4975-94D8-C2ECCBEBAAB1Q51625827-34447C1A-2E2A-4D81-A078-36F15E13B054Q54378698-6134878B-0FF1-426C-8D1C-99CDDC9BACE4
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Taurine and skeletal muscle disorders.
@ast
Taurine and skeletal muscle disorders.
@en
type
label
Taurine and skeletal muscle disorders.
@ast
Taurine and skeletal muscle disorders.
@en
prefLabel
Taurine and skeletal muscle disorders.
@ast
Taurine and skeletal muscle disorders.
@en
P2093
P50
P1476
Taurine and skeletal muscle disorders.
@en
P2093
Bodvael Fraysse
Domenico Tricarico
Jean-François Desaphy
Rosa Burdi
P304
P356
10.1023/B:NERE.0000010442.89826.9C
P577
2004-01-01T00:00:00Z
P6179
1043966108